Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota.

ABSTRACT: Emerging evidence suggests that gut microbiota may influence the response to chemotherapy. We sought to characterize the effects of 5 fluorouracil (5FU) chemotherapy on colon inflammation and functional measures in colorectal cancer (CRC) and to further determine whether gut microbiota can influence this response. 50 C57BL/6 were randomized into four groups; Control?+?Vehicle (n?=?10), Control?+?5FU (n?=?10), AOM/DSS?+?Vehicle (n?=?15), and AOM/DSS?+?5FU (n?=?15). CRC was induced chemically by a single 10?mg/kg injection of azoxymethane (AOM) followed by two cycles (2% and 1%) of dextran sodium sulfate (DSS). Mice were then treated with 3 cycles of vehicle or 5FU (cycle 1: 40?mg/kg, cycle 2?+?3: 20?mg/kg). Functional tests (grip strength and run-to-fatigue) were performed prior to 5FU treatment (baseline) and at the completion of the second cycle of 5FU. Following the third 5FU cycle, mice were euthanized and the colon was evaluated for expression of inflammatory genes using RT-qPCR and stool samples were profiled using 16S rRNA sequencing. A second experiment used fecal microbiota transplantation from 5FU treated mice to control mice (n?=?10-15/group) to determine whether 5FU associated changes in the microbiota could influence functional measures and colon inflammation. 5FU reduced grip strength (p?

SUBMITTER: Sougiannis AT 

PROVIDER: S-EPMC6660349 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature